Cision PR Newswire

XCOTTON Joins the Conversation at IFA 2026: Why the Future of Commerce Goes Beyond Checkout

LOS ANGELES and NEW YORK and LAS VEGAS, Sept. 5, 2026 /PRNewswire/ -- As the global consumer technology industry gathers in Berlin for IFA 2026, thousands of...

ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026

BERLIN, Sept. 5, 2026 /PRNewswire/ -- ToolDance, a technology company focused on intelligent desktop...

From Trust to Value: Miles Group Signs Bo Jin and Isaac Lam, Launching into the Athlete Representation Track

HONG KONG, Sept. 5, 2026 /PRNewswire/ -- Miles Group, specializing in international sports marketing,...

Amwell Receives Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms

Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical...

EQT Infrastructure VI holds final close at its hard-cap, raising EUR 21.5 billion in total commitments

EQT Infrastructure VI raises EUR 21.5 billion in total commitments, including EUR 21.3 billion in fee-generating assets under management, exceeding the...

137th Canton Fair Promotes Innovation and Trade in Hong Kong and Macao, Bringing Regional Economy to New Heights

GUANGZHOU, China, March 28, 2025 /PRNewswire/ -- The 137th Canton Fair, set to commence on April 15th in Guangzhou, successfully hosted two promotion conferences on...

DAHON Unveils its Latest 2025 lineup at Taipei Cycle Show, Pushing the Boundary of Cycling Innovation

TAIPEI, March 28, 2025 /PRNewswire/ -- The highly anticipated Taipei Cycle Show (TCS) 2025 kicked off at Nangang Exhibition Center Halls 1 & 2. DAHON,...

Geely’s Eric Li Wears AR Glasses to Speak at Global Investment Promotion Conference in Shanghai

SHANGHAI, March 28, 2025 /PRNewswire/ -- "For today's speech, I implanted the speech script into my glasses." Eric Li, chairman of Geely Holding Group...

Viva Biotech’s Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection

SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a...